NCT02934139View on ClinicalTrials.gov

MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Cystic Fibrosis
Interventions
DRUG

Cavosonstat

CFTR modulator that stabilizes CFTR

OTHER

Placebo

Matched placebo

Trial Locations (1)

80228

DaVita Clinical Research, Lakewood

Sponsors
All Listed Sponsors
lead

Nivalis Therapeutics, Inc.

INDUSTRY

NCT02934139 - MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9) | Biotech Hunter | Biotech Hunter